{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:27:00Z","timestamp":1787927220376,"version":"build-2784847793"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10787-026-02313-3","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T16:07:02Z","timestamp":1782576422000},"page":"5329-5342","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A new paradigm in Parkinson\u2019s disease: kidney-origin \u03b1-synuclein pathology driven by PKC signaling and aurothioglucose"],"prefix":"10.1007","volume":"34","author":[{"given":"Kanika","family":"Vashisht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahendra Singh","family":"Ashawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6163-9102","authenticated-orcid":false,"given":"Ashish","family":"Baldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3692-2774","authenticated-orcid":false,"given":"Shiv Kumar","family":"Kushawaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"issue":"1","key":"2313_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s41983-026-01132-1","volume":"62","author":"N Aderinto","year":"2026","unstructured":"Aderinto N et al (2026) The impact of kidney dysfunction on blood-brain barrier integrity and neurological conditions. Egypt J Neurol Psychiatry Neurosurg 62(1):65. https:\/\/doi.org\/10.1186\/s41983-026-01132-1","journal-title":"Egypt J Neurol Psychiatry Neurosurg"},{"key":"2313_CR2","unstructured":"Adesso S (2017) Neurodegeneration in Chronic Kidney Disease: role of neuroinflammation and uremic toxins. Dissertation, SBARDELLA, Gianluca"},{"key":"2313_CR3","doi-asserted-by":"publisher","unstructured":"Ahanger IA, Ashraf GM, Sharma A, Islam A (2024) Comprehensive perspective towards the management of proteinopathies by elucidating protein misfolding and aggregation. CNS & Neurol Disord-Drug Targets-CNS Neurol Disorders. 23(2):153\u2013180. https:\/\/doi.org\/10.2174\/1871527322666230306085937","DOI":"10.2174\/1871527322666230306085937"},{"issue":"3","key":"2313_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2174\/1389201016666150118132457","volume":"16","author":"V Aires","year":"2015","unstructured":"Aires V, Delmas D (2015) Common pathways in health benefit properties of RSV in cardiovascular diseases, cancers and degenerative pathologies. Curr Pharm Biotechnol 16(3):219\u2013244","journal-title":"Curr Pharm Biotechnol"},{"issue":"10","key":"2313_CR5","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.3390\/biomedicines10102649","volume":"10","author":"K Albert","year":"2022","unstructured":"Albert K et al (2022) Cellular models of Alpha-Synuclein aggregation: what have we learned and implications for future study. Biomedicines 10(10):2649. https:\/\/doi.org\/10.3390\/biomedicines10102649","journal-title":"Biomedicines"},{"issue":"1","key":"2313_CR6","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1038\/s41467-024-46554-8","volume":"15","author":"S Amartumur","year":"2024","unstructured":"Amartumur S et al (2024) Neuropathogenesis-on-chips for neurodegenerative diseases. Nat Commun 15(1):2219. https:\/\/doi.org\/10.1038\/s41467-024-46554-8","journal-title":"Nat Commun"},{"issue":"1","key":"2313_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1196\/annals.1356.011","volume":"1057","author":"F Battaini","year":"2005","unstructured":"Battaini F, Pascale A (2005) Protein kinase C signal transduction regulation in physiological and pathological aging. Ann N Y Acad Sci 1057(1):177\u2013192. https:\/\/doi.org\/10.1196\/annals.1356.011","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"2313_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/mds.27895","volume":"35","author":"G Bellomo","year":"2020","unstructured":"Bellomo G, Paciotti S, Gatticchi L, Parnetti L (2020) The vicious cycle between \u03b1-synuclein aggregation and autophagic\u2010lysosomal dysfunction. Mov Disord 35(1):34\u201344. https:\/\/doi.org\/10.1002\/mds.27895","journal-title":"Mov Disord"},{"issue":"6","key":"2313_CR9","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.3390\/ijms26062440","volume":"26","author":"AI Beltran-Velasco","year":"2025","unstructured":"Beltran-Velasco AI, Clemente-Su\u00e1rez VJ (2025) Impact of peripheral inflammation on blood\u2013brain barrier dysfunction and its role in neurodegenerative diseases. Int J Mol Sci 26(6):2440. https:\/\/doi.org\/10.3390\/ijms26062440","journal-title":"Int J Mol Sci"},{"key":"2313_CR10","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3389\/fnins.2019.01399","volume":"13","author":"LD Bernal-Conde","year":"2020","unstructured":"Bernal-Conde LD et al (2020) Alpha-synuclein physiology and pathology: a perspective on cellular structures and organelles. Front NeuroSci 13:1399. https:\/\/doi.org\/10.3389\/fnins.2019.01399","journal-title":"Front NeuroSci"},{"key":"2313_CR200","doi-asserted-by":"publisher","unstructured":"Bisi et al (2021) \u03b1-Synuclein: An All-Inclusive Trip Around its Structure, Infl uencing Factors and Applied Techniques. Front Chem 9:1\u201328. https:\/\/doi.org\/10.3389\/fchem.2021.666585","DOI":"10.3389\/fchem.2021.666585"},{"issue":"11","key":"2313_CR11","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.3390\/antiox11112161","volume":"11","author":"G Bj\u00f8rklund","year":"2022","unstructured":"Bj\u00f8rklund G et al (2022) The role of the thioredoxin system in brain diseases. Antioxidants 11(11):2161. https:\/\/doi.org\/10.3390\/antiox11112161","journal-title":"Antioxidants"},{"key":"2313_CR12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3389\/fimmu.2012.00423","volume":"3","author":"AR Black","year":"2013","unstructured":"Black AR, Black JD (2013) Protein kinase C signaling and cell cycle regulation. Front Immunol 3:423. https:\/\/doi.org\/10.3389\/fimmu.2012.00423","journal-title":"Front Immunol"},{"issue":"s2","key":"2313_CR13","doi-asserted-by":"publisher","first-page":"S281","DOI":"10.3233\/JPD-1917","volume":"9","author":"P Borghammer","year":"2019","unstructured":"Borghammer P, Van Den Berge N (2019) Brain-first versus gut-first Parkinson\u2019s disease: a hypothesis. J Parkinson\u2019s disease 9(s2):S281\u2013S295. https:\/\/doi.org\/10.3233\/JPD-1917","journal-title":"J Parkinson\u2019s disease"},{"issue":"1","key":"2313_CR14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, R\u00fcb U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res 318(1):121\u2013134. https:\/\/doi.org\/10.1007\/s00441-004-0956-9","journal-title":"Cell Tissue Res"},{"key":"2313_CR15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fnins.2018.00080","volume":"12","author":"JC Bridi","year":"2018","unstructured":"Bridi JC, Hirth F (2018) Mechanisms of \u03b1-synuclein induced synaptopathy in Parkinson\u2019s disease. Front NeuroSci 12:80. https:\/\/doi.org\/10.3389\/fnins.2018.00080","journal-title":"Front NeuroSci"},{"key":"2313_CR16","unstructured":"Brijmohan A (2017) Role of HDAC6 in transcription factor EB mediated clearance of misfolded proteins in chronic kidney disease. University of Toronto, Canada"},{"key":"2313_CR202","doi-asserted-by":"publisher","unstructured":"Calabresi P et al (2023) Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell death & disease, 14(3), 176. https:\/\/doi.org\/10.1038\/s41419-023-05672-9","DOI":"10.1038\/s41419-023-05672-9"},{"key":"2313_CR17","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3389\/fnins.2019.00382","volume":"13","author":"A Canerina-Amaro","year":"2019","unstructured":"Canerina-Amaro A et al (2019) Differential aggregation and phosphorylation of alpha synuclein in membrane compartments associated with Parkinson disease. Front NeuroSci 13:382. https:\/\/doi.org\/10.3389\/fnins.2019.00382","journal-title":"Front NeuroSci"},{"issue":"12","key":"2313_CR18","doi-asserted-by":"publisher","first-page":"6517","DOI":"10.3390\/ijms22126517","volume":"22","author":"A Cardinale","year":"2021","unstructured":"Cardinale A, Calabrese V, De Iure A, Picconi B (2021) Alpha-synuclein as a prominent actor in the inflammatory synaptopathy of Parkinson\u2019s disease. Int J Mol Sci 22(12):6517. https:\/\/doi.org\/10.3390\/ijms22126517","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2313_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4161\/cbt.23615","volume":"14","author":"AD Carmo","year":"2013","unstructured":"Carmo AD, Bal\u00e7a-Silva J, Matias D, Lopes M (2013) PKC signaling in glioblastoma. Cancer Biol Ther 14(4):287\u2013294. https:\/\/doi.org\/10.4161\/cbt.23615","journal-title":"Cancer Biol Ther"},{"issue":"10","key":"2313_CR20","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.3390\/antiox11101921","volume":"11","author":"S Chakraborty","year":"2022","unstructured":"Chakraborty S et al (2022) S-denitrosylation: a crosstalk between glutathione and redoxin systems. Antioxidants 11(10):1921. https:\/\/doi.org\/10.3390\/antiox11101921","journal-title":"Antioxidants"},{"issue":"3","key":"2313_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.cmet.2018.08.014","volume":"28","author":"J Chaudhuri","year":"2018","unstructured":"Chaudhuri J et al (2018) The role of advanced glycation end products in aging and metabolic diseases: bridging association and causality. Cell Metabol 28(3):337\u2013352","journal-title":"Cell Metabol"},{"issue":"27","key":"2313_CR22","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.2174\/138161206778343028","volume":"12","author":"CC Chen","year":"2006","unstructured":"Chen CC (2006) Signal transduction pathways of inflammatory gene expressions and therapeutic implications. Curr Pharm Design 12(27):3497\u20133508. https:\/\/doi.org\/10.2174\/138161206778343028","journal-title":"Curr Pharm Design"},{"issue":"4","key":"2313_CR23","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.3892\/mmr.2016.4948","volume":"13","author":"WW Chen","year":"2016","unstructured":"Chen WW, Zhang X, Huang WJ (2016) Role of neuroinflammation in neurodegenerative diseases. Mol Med Rep 13(4):3391\u20133396. https:\/\/doi.org\/10.3892\/mmr.2016.4948","journal-title":"Mol Med Rep"},{"issue":"1","key":"2313_CR24","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s10020-025-01208-3","volume":"31","author":"Y Chen","year":"2025","unstructured":"Chen Y et al (2025) The interplay of iron, oxidative stress, and \u03b1-synuclein in Parkinson\u2019s disease progression. Mol Med 31(1):154. https:\/\/doi.org\/10.1186\/s10020-025-01208-3","journal-title":"Mol Med"},{"issue":"3","key":"2313_CR25","doi-asserted-by":"publisher","first-page":"443","DOI":"10.14283\/jpad.2023.35","volume":"10","author":"HC Chi","year":"2023","unstructured":"Chi HC et al (2023) Adult renal dysfunction and risk of dementia or cognitive decline: brain-kidney axis hypothesis based on a systematic review and meta-analysis. J Prev Alzheimer\u2019s Dis 10(3):443\u2013452. https:\/\/doi.org\/10.14283\/jpad.2023.35","journal-title":"J Prev Alzheimer\u2019s Disease"},{"issue":"2","key":"2313_CR26","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3390\/cells9020453","volume":"9","author":"F Collino","year":"2020","unstructured":"Collino F et al (2020) Extracellular vesicles derived from induced pluripotent stem cells promote renoprotection in acute kidney injury model. Cells 9(2):453. https:\/\/doi.org\/10.3390\/cells9020453","journal-title":"Cells"},{"issue":"1","key":"2313_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13064-025-00210-z","volume":"20","author":"J Cui","year":"2025","unstructured":"Cui J, Zhao C (2025) Autophagy and apoptosis in Alzheimer\u2019s disease-associated neurons. Discover Neurosci 20(1):11. https:\/\/doi.org\/10.1186\/s13064-025-00210-z","journal-title":"Discover Neurosci"},{"issue":"6","key":"2313_CR28","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3390\/biom15060892","volume":"15","author":"C Dai","year":"2025","unstructured":"Dai C, Khalil RA (2025) Calcium signaling dynamics in vascular cells and their dysregulation in vascular disease. Biomolecules 15(6):892. https:\/\/doi.org\/10.3390\/biom15060892","journal-title":"Biomolecules"},{"issue":"10","key":"2313_CR29","doi-asserted-by":"publisher","first-page":"913","DOI":"10.2174\/156802609789378254","volume":"9","author":"M Di Napoli","year":"2009","unstructured":"Di Napoli M (2009) New molecular avenues in Parkinson\u2019s disease therapy. Curr Top Med Chem 9(10):913\u2013948. https:\/\/doi.org\/10.2174\/156802609789378254","journal-title":"Curr Top Med Chem"},{"key":"2313_CR30","unstructured":"dos Santos PAR (2013) Role of selective kinases and Gdnf on iron-mediated alpha-synuclein phosphorylation-relevance to Parkinson\u2019s disease. Universidade de Coimbra, Portugal."},{"issue":"45","key":"2313_CR32","doi-asserted-by":"publisher","first-page":"38210","DOI":"10.1074\/jbc.M112.392225","volume":"287","author":"Y Du","year":"2012","unstructured":"Du Y, Zhang H, Lu J, Holmgren A (2012) Glutathione and glutaredoxin act as a backup of human thioredoxin reductase 1 to reduce thioredoxin 1, preventing cell death by aurothioglucose. J Biol Chem 287(45):38210\u201338219","journal-title":"J Biol Chem"},{"issue":"10","key":"2313_CR31","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41578-018-0038-3","volume":"3","author":"B Du","year":"2018","unstructured":"Du B, Yu M, Zheng J (2018) Transport and interactions of nanoparticles in the kidneys. Nat Rev Mater 3(10):358\u2013374. https:\/\/doi.org\/10.1038\/s41578-018-0038-3","journal-title":"Nat Reviews Mater"},{"issue":"3","key":"2313_CR33","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1042\/BJ20081056","volume":"415","author":"V Duronio","year":"2008","unstructured":"Duronio V (2008) The life of a cell: apoptosis regulation by the PI3K\/PKB pathway. Biochem J 415(3):333\u2013344. https:\/\/doi.org\/10.1042\/BJ20081056","journal-title":"Biochem J"},{"issue":"8","key":"2313_CR34","doi-asserted-by":"publisher","first-page":"2400623","DOI":"10.1002\/adbi.202400623","volume":"9","author":"F Ebrahimi","year":"2025","unstructured":"Ebrahimi F et al (2025) The potential for extracellular vesicles in nanomedicine: a review of recent advancements and challenges ahead. Adv Biol 9(8):2400623. https:\/\/doi.org\/10.1002\/adbi.202400623","journal-title":"Adv Biology"},{"issue":"1","key":"2313_CR35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41531-022-00307-w","volume":"8","author":"SL Farrow","year":"2022","unstructured":"Farrow SL, Cooper AA, O\u2019Sullivan JM (2022) Redefining the hypotheses driving Parkinson\u2019s disease research. npj Parkinson\u2019s Dis 8(1):45. https:\/\/doi.org\/10.1038\/s41531-022-00307-w","journal-title":"npj Parkinson\u2019s Disease"},{"issue":"6","key":"2313_CR36","doi-asserted-by":"publisher","first-page":"5914","DOI":"10.3390\/ijms24065914","volume":"24","author":"G Forloni","year":"2023","unstructured":"Forloni G (2023) Alpha synuclein: neurodegeneration and inflammation. Int J Mol Sci 24(6):5914. https:\/\/doi.org\/10.3390\/ijms24065914","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2313_CR37","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s40478-014-0176-9","volume":"2","author":"RM Gir\u00e1ldez-P\u00e9rez","year":"2014","unstructured":"Gir\u00e1ldez-P\u00e9rez RM, Antol\u00edn-Vallesp\u00edn M, Mu\u00f1oz MD, S\u00e1nchez-Capelo A (2014) Models of \u03b1-synuclein aggregation in Parkinson\u2019s disease. Acta Neuropathol Commun 2(1):176. https:\/\/doi.org\/10.1186\/s40478-014-0176-9","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"2313_CR38","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2174\/1381612825666190319114641","volume":"25","author":"EY Gusev","year":"2019","unstructured":"Gusev EY, Zotova NV (2019) Cellular stress and general pathological processes. Curr Pharm Design 25(3):251\u2013297. https:\/\/doi.org\/10.2174\/1381612825666190319114641","journal-title":"Curr Pharm Design"},{"issue":"11","key":"2313_CR39","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s12264-025-01516-y","volume":"41","author":"Y Han","year":"2025","unstructured":"Han Y, Wang Y, Lu Y, Xie C, Wu D (2025) \u03b1-synuclein pathology from kidney to brain in Parkinson\u2019s disease. Neurosci Bull 41(11):2103\u20132105. https:\/\/doi.org\/10.1007\/s12264-025-01516-y","journal-title":"Neurosci Bull"},{"issue":"9","key":"2313_CR40","doi-asserted-by":"publisher","first-page":"105461","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105461","volume":"30","author":"RM Hanna","year":"2021","unstructured":"Hanna RM et al (2021) Renal-cerebral pathophysiology: the interplay between chronic kidney disease and cerebrovascular disease. J Stroke Cerebrovasc Dis 30(9):105461. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.105461","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"2","key":"2313_CR41","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2174\/1389201024666230606143827","volume":"25","author":"RK Harwansh","year":"2024","unstructured":"Harwansh RK, Mishra S, Mazumder R, Deshmukh R, Rahman A (2024) Recent updates on transdermal drug delivery approaches for the management of gout and its clinical perspective. Curr Pharm Biotechnol 25(2):159\u2013178. https:\/\/doi.org\/10.2174\/1389201024666230606143827","journal-title":"Curr Pharm Biotechnol"},{"issue":"6","key":"2313_CR42","doi-asserted-by":"publisher","first-page":"e70124","DOI":"10.1111\/jnc.70124","volume":"169","author":"MS Ho","year":"2025","unstructured":"Ho MS (2025) Clearance pathways for \u03b1-synuclein in Parkinson\u2019s disease. J Neurochem 169(6):e70124. https:\/\/doi.org\/10.1111\/jnc.70124","journal-title":"J Neurochem"},{"issue":"18","key":"2313_CR43","doi-asserted-by":"publisher","first-page":"10808","DOI":"10.3390\/ijms231810808","volume":"23","author":"M Huang","year":"2022","unstructured":"Huang M et al (2022) Impact of environmental risk factors on mitochondrial dysfunction, neuroinflammation, protein misfolding, and oxidative stress in the etiopathogenesis of Parkinson\u2019s disease. Int J Mol Sci 23(18):10808. https:\/\/doi.org\/10.3390\/ijms231810808","journal-title":"Int J Mol Sci"},{"issue":"2\u20133","key":"2313_CR44","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1515\/jbcpp-2024-0220","volume":"36","author":"A Javed","year":"2025","unstructured":"Javed A et al (2025) Navigating nephropathy and nephrotoxicity: understanding pathophysiology unveiling clinical manifestations, and exploring treatment approaches. J Basic Clin Physiol Pharmacol 36(2\u20133):69\u201393","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"2313_CR45","unstructured":"Jiang X (2023) Targeting Microsomal Prostaglandin E Synthase-1 by Sonlicromanol\u2019s Metabolite KH176m as a Therapeutic Strategy. Dissertation, Radboud University Medical Center, Nijmegen, The Netherlands"},{"issue":"15","key":"2313_CR46","doi-asserted-by":"publisher","first-page":"8582","DOI":"10.3390\/ijms23158582","volume":"23","author":"FF Jubaidi","year":"2022","unstructured":"Jubaidi FF et al (2022) The role of PKC-MAPK signalling pathways in the development of hyperglycemia-induced cardiovascular complications. Int J Mol Sci 23(15):8582. https:\/\/doi.org\/10.3390\/ijms23158582","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2313_CR47","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3390\/cells9030553","volume":"9","author":"HN Kaleli","year":"2020","unstructured":"Kaleli HN, Ozer E, Kaya VO, Kutlu O (2020) Protein kinase C isozymes and autophagy during neurodegenerative disease progression. Cells 9(3):553. https:\/\/doi.org\/10.3390\/cells9030553","journal-title":"Cells"},{"issue":"7","key":"2313_CR48","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/08916934.2021.1963959","volume":"54","author":"G Kaur","year":"2021","unstructured":"Kaur G, Sharma A, Bhatnagar A (2021) Role of oxidative stress in pathophysiology of rheumatoid arthritis: insights into NRF2-KEAP1 signalling. Autoimmunity 54(7):385\u2013397. https:\/\/doi.org\/10.1080\/08916934.2021.1963959","journal-title":"Autoimmunity"},{"issue":"1","key":"2313_CR49","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2172-11-26","volume":"11","author":"H Khalaf","year":"2010","unstructured":"Khalaf H, Jass J, Olsson PE (2010) Differential cytokine regulation by NF-\u03baB and AP-1 in Jurkat T-cells. BMC Immunol 11(1):26. https:\/\/doi.org\/10.1186\/1471-2172-11-26","journal-title":"BMC Immunol"},{"issue":"13","key":"2313_CR50","doi-asserted-by":"publisher","first-page":"6416","DOI":"10.3390\/ijms26136416","volume":"26","author":"MS Khan","year":"2025","unstructured":"Khan MS, Nasiripour S, Bopassa JC (2025) Parkinson\u2019s disease signaling pathways, molecular mechanisms, and potential therapeutic strategies: a comprehensive review. Int J Mol Sci 26(13):6416. https:\/\/doi.org\/10.3390\/ijms26136416","journal-title":"Int J Mol Sci"},{"issue":"19","key":"2313_CR51","doi-asserted-by":"publisher","first-page":"10797","DOI":"10.3390\/ijms251910797","volume":"25","author":"S Kotarba","year":"2024","unstructured":"Kotarba S et al (2024) Potential mechanisms of tunneling nanotube formation and their role in pathology spread in Alzheimer\u2019s disease and other proteinopathies. Int J Mol Sci 25(19):10797. https:\/\/doi.org\/10.3390\/ijms251910797","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2313_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11064-025-04607-4","volume":"50","author":"H Kumar","year":"2025","unstructured":"Kumar H et al (2025) Saroglitazar at the crossroads of metabolic and neurodegenerative disease: a critical review of the hepato-neuro axis and translational horizons. Neurochem Res 50(6):1\u201312. https:\/\/doi.org\/10.1007\/s11064-025-04607-4","journal-title":"Neurochem Res"},{"key":"2313_CR53","doi-asserted-by":"publisher","unstructured":"Kumari S et al (2026) \u03b1-synuclein as a molecular link between Parkinson\u2019s disease and chronic kidney disease: insights into the kidney-brain axis. Metabolic Brain Dis (2026) 41:106. https:\/\/doi.org\/10.1007\/s11011-026-01864-2","DOI":"10.1007\/s11011-026-01864-2"},{"issue":"2","key":"2313_CR54","doi-asserted-by":"publisher","first-page":"756","DOI":"10.52711\/0974-360X.2024.00118","volume":"17","author":"SK Kushawaha","year":"2024","unstructured":"Kushawaha SK, Ashawat MS, Baldi A (2024) Neuroprotective effect of aurothioglucose-loaded PLGA nanoparticles in an aluminum chloride-induced rat model of Alzheimer\u2019s disease. Res J Pharm Technol 17(2):756\u2013762. https:\/\/doi.org\/10.52711\/0974-360X.2024.00118","journal-title":"Res J Pharm Technol"},{"issue":"11","key":"2313_CR56","doi-asserted-by":"publisher","first-page":"6389","DOI":"10.1007\/s10787-025-01981-x","volume":"33","author":"SK Kushawaha","year":"2025","unstructured":"Kushawaha SK et al (2025a) Asperuloside: an emerging therapeutic candidate for Parkinson\u2019s disease through molecular mechanistic insights. Inflammopharmacology 33(11):6389\u20136399. https:\/\/doi.org\/10.1007\/s10787-025-01981-x","journal-title":"Inflammopharmacology"},{"key":"2313_CR57","doi-asserted-by":"publisher","unstructured":"Kushawaha SK (2025b) Targeting protein kinase C signaling cascades in alzheimer\u2019s disease: emerging neuroprotective roles of aurothioglucose. Inflammopharmacology  1\u201312. https:\/\/doi.org\/10.1007\/s10787-025-02077-2","DOI":"10.1007\/s10787-025-02077-2"},{"key":"2313_CR55","doi-asserted-by":"publisher","unstructured":"Kushawaha SK et al (2024) Aurothioglucose encapsulated nanoparticles fostered neuroprotection in streptozotocin-induced Alzheimer\u2019s disease. Brain Res 1834:148906. https:\/\/doi.org\/10.1016\/j.brainres.2024.148906","DOI":"10.1016\/j.brainres.2024.148906"},{"key":"2313_CR58","doi-asserted-by":"crossref","unstructured":"Ladiges W, Ikeno Y, Wang L (2020) Resilience in aging and age-related disease. Abstracts from the 2019 Barshop Conference on Aging. Aging Pathobiol Therapeut 2(1):01\u201313","DOI":"10.31491\/APT.2020.03.006"},{"issue":"14","key":"2313_CR59","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1093\/hmg\/dds143","volume":"21","author":"I Lastres-Becker","year":"2012","unstructured":"Lastres-Becker I et al (2012) \u03b1-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson\u2019s disease. Hum Mol Genet 21(14):3173\u20133192. https:\/\/doi.org\/10.1093\/hmg\/dds143","journal-title":"Hum Mol Genet"},{"key":"2313_CR203","doi-asserted-by":"publisher","unstructured":"Lee J et al (2023) Targeted degradation of \u237a-synuclein aggregates in Parkinson\u2019s disease using the AUTOTAC technology. Mol Neurodegeneration 18:41. https:\/\/doi.org\/10.1186\/s13024-023-00630-7","DOI":"10.1186\/s13024-023-00630-7"},{"issue":"11","key":"2313_CR60","doi-asserted-by":"publisher","first-page":"e70474","DOI":"10.1002\/mco2.70474","volume":"6","author":"Y Li","year":"2025","unstructured":"Li Y et al (2025) Protein kinase C family: structures, biological functions, diseases, and pharmaceutical interventions. MedComm 6(11):e70474. https:\/\/doi.org\/10.1002\/mco2.70474","journal-title":"MedComm"},{"issue":"21","key":"2313_CR61","doi-asserted-by":"publisher","first-page":"5312","DOI":"10.3390\/ijms20215312","volume":"20","author":"KJ Lin","year":"2019","unstructured":"Lin KJ et al (2019) The overcrowded crossroads: mitochondria, alpha-synuclein, and the endo-lysosomal system interaction in Parkinson\u2019s disease. Int J Mol Sci 20(21):5312. https:\/\/doi.org\/10.3390\/ijms20215312","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2313_CR62","doi-asserted-by":"publisher","first-page":"5012129","DOI":"10.1155\/2017\/5012129","volume":"2017","author":"F Longhena","year":"2017","unstructured":"Longhena F et al (2017) The contribution of \u03b1-synuclein spreading to Parkinson\u2019s disease synaptopathy. Neural Plast 2017(1):5012129. https:\/\/doi.org\/10.1155\/2017\/5012129","journal-title":"Neural Plast"},{"issue":"10","key":"2313_CR63","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.3390\/ijms18102222","volume":"18","author":"M Maywald","year":"2017","unstructured":"Maywald M, Wessels I, Rink L (2017) Zinc signals and immunity. Int J Mol Sci 18(10):2222. https:\/\/doi.org\/10.3390\/ijms18102222","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2313_CR64","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1042\/CS20160927","volume":"131","author":"AS Miranda","year":"2017","unstructured":"Miranda AS et al (2017) Kidney\u2013brain axis inflammatory cross-talk: from bench to bedside. Clin Sci 131(11):1093\u20131105. https:\/\/doi.org\/10.1042\/CS20160927","journal-title":"Clin Ccience"},{"issue":"3","key":"2313_CR65","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/diabetology7030053","volume":"7","author":"H Mirmiranpour","year":"2026","unstructured":"Mirmiranpour H, Arden C (2026) The interplay between reactive oxygen species, glucose metabolism and NF-kB in the pathogenesis of type 2 diabetes. Diabetology 7(3):53. https:\/\/doi.org\/10.3390\/diabetology7030053","journal-title":"Diabetology"},{"issue":"1","key":"2313_CR66","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s11033-025-10484-5","volume":"52","author":"M Mohan","year":"2025","unstructured":"Mohan M, Mannan A, Singh TG (2025) Unravelling the role of protein kinase R (PKR) in neurodegenerative disease: a review. Mol Biol Rep 52(1):377. https:\/\/doi.org\/10.1007\/s11033-025-10484-5","journal-title":"Mol Biol Rep"},{"issue":"3","key":"2313_CR67","doi-asserted-by":"publisher","first-page":"360","DOI":"10.2174\/1568026615666150827094500","volume":"16","author":"C Nardon","year":"2016","unstructured":"Nardon C, Fregona D (2016) Gold (III) complexes in the oncological preclinical arena: from aminoderivatives to peptidomimetics. Curr Top Med Chem 16(3):360\u2013380","journal-title":"Curr Top Med Chem"},{"key":"2313_CR68","doi-asserted-by":"publisher","first-page":"105760","DOI":"10.1016\/j.neuint.2024.105760","volume":"177","author":"S Negi","year":"2024","unstructured":"Negi S, Khurana N, Duggal N (2024) The misfolding mystery: \u03b1-synuclein and the pathogenesis of Parkinson\u2019s disease. Neurochem Int 177:105760. https:\/\/doi.org\/10.1016\/j.neuint.2024.105760","journal-title":"Neurochem Int"},{"issue":"4","key":"2313_CR69","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2174\/187153006779025685","volume":"6","author":"T Okamoto","year":"2006","unstructured":"Okamoto T (2006) NF-\u03ba B and rheumatic diseases. Endocrine, Metabol Immune Disord-Drug Targets (Formerly Current Drug Targets-Immune, Endocr Metabol Disord) 6(4):359\u2013372. https:\/\/doi.org\/10.2174\/187153006779025685","journal-title":"Endocr Metabolic Disorders)"},{"issue":"5","key":"2313_CR70","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2174\/138161207780162944","volume":"13","author":"T Okamoto","year":"2007","unstructured":"Okamoto T, Sanda T, Asamitsu K (2007) NF-\u03baB signaling and carcinogenesis. Curr Pharm Design 13(5):447\u2013462. https:\/\/doi.org\/10.2174\/138161207780162944","journal-title":"Curr Pharm Design"},{"issue":"3","key":"2313_CR71","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.3390\/ijms10031226","volume":"10","author":"D Olivares","year":"2009","unstructured":"Olivares D et al (2009) Physiological and pathological role of alpha-synuclein in Parkinson\u2019s disease through iron-mediated oxidative stress; the role of a putative iron-responsive element. Int J Mol Sci 10(3):1226\u20131260. https:\/\/doi.org\/10.3390\/ijms10031226","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2313_CR72","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3390\/antiox15030369","volume":"15","author":"V Otasevic","year":"2026","unstructured":"Otasevic V et al (2026) The role of ferroptosis in diabetes pathogenesis: therapeutic implications of hydrogen sulfide and its reactive metabolites. Antioxidants 15(3):369. https:\/\/doi.org\/10.3390\/antiox15030369","journal-title":"Antioxidants"},{"issue":"5","key":"2313_CR73","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1046\/j.1523-1755.2001.0590051789.x","volume":"59","author":"BJ Padanilam","year":"2001","unstructured":"Padanilam BJ (2001) Induction and subcellular localization of protein kinase C isozymes following renal ischemia. Kidney Int 59(5):1789\u20131797. https:\/\/doi.org\/10.1046\/j.1523-1755.2001.0590051789.x","journal-title":"Kidney Int"},{"issue":"22","key":"2313_CR74","doi-asserted-by":"publisher","first-page":"12467","DOI":"10.3390\/ijms222212467","volume":"22","author":"FJ Padilla-God\u00ednez","year":"2021","unstructured":"Padilla-God\u00ednez FJ et al (2021) Protein misfolding and aggregation: the relatedness between Parkinson\u2019s disease and hepatic endoplasmic reticulum storage disorders. Int J Mol Sci 22(22):12467. https:\/\/doi.org\/10.3390\/ijms222212467","journal-title":"Int J Mol Sci"},{"issue":"10","key":"2313_CR75","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3390\/biom11101508","volume":"11","author":"A Picca","year":"2021","unstructured":"Picca A et al (2021) Mitochondrial dysfunction, protein misfolding and neuroinflammation in Parkinson\u2019s disease: roads to biomarker discovery. Biomolecules 11(10):1508. https:\/\/doi.org\/10.3390\/biom11101508","journal-title":"Biomolecules"},{"issue":"3","key":"2313_CR76","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3934\/Neuroscience.2023017","volume":"10","author":"S Ramesh","year":"2023","unstructured":"Ramesh S, Arachchige ASPM (2023) Depletion of dopamine in Parkinson\u2019s disease and relevant therapeutic options: a review of the literature. AIMS Neurosci 10(3):200. https:\/\/doi.org\/10.3934\/Neuroscience.2023017","journal-title":"AIMS Neurosci"},{"key":"2313_CR201","doi-asserted-by":"publisher","unstructured":"Ranjan (2026) Synaptic vesicle architecture modulates \u03b1-synuclein conformation and pathogenic transitions in Parkinson\u2019s disease. Biosci Rep 46(6):BSR20260364. https:\/\/doi.org\/10.1042\/BSR20260364","DOI":"10.1042\/BSR20260364"},{"issue":"9","key":"2313_CR77","doi-asserted-by":"publisher","first-page":"4956","DOI":"10.3390\/ijms22094956","volume":"22","author":"M Rasheed","year":"2021","unstructured":"Rasheed M et al (2021) Epigenetic regulation of neuroinflammation in Parkinson\u2019s disease. Int J Mol Sci 22(9):4956. https:\/\/doi.org\/10.3390\/ijms22094956","journal-title":"Int J Mol Sci"},{"issue":"12","key":"2313_CR78","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1089\/ars.2010.3511","volume":"14","author":"M Rodriguez-Munoz","year":"2011","unstructured":"Rodriguez-Munoz M et al (2011) NO-released zinc supports the simultaneous binding of Raf-1 and PKC\u03b3 cysteine-rich domains to HINT1 protein at the mu-opioid receptor. Antioxid Redox Signal 14(12):2413\u20132425. https:\/\/doi.org\/10.1089\/ars.2010.3511","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"2313_CR79","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s12035-013-8465-z","volume":"48","author":"M Rodr\u00edguez-Mu\u00f1oz","year":"2013","unstructured":"Rodr\u00edguez-Mu\u00f1oz M, Garz\u00f3n J (2013) Nitric oxide and zinc-mediated protein assemblies involved in mu opioid receptor signaling. Mol Neurobiol 48(3):769\u2013782. https:\/\/doi.org\/10.1007\/s12035-013-8465-z","journal-title":"Mol Neurobiol"},{"issue":"3","key":"2313_CR80","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3892\/ijmm.4.3.223","volume":"4","author":"KA Roebuck","year":"1999","unstructured":"Roebuck KA (1999) Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB. Int J Mol Med 4(3):223\u2013253. https:\/\/doi.org\/10.3892\/ijmm.4.3.223","journal-title":"Int J Mol Med"},{"issue":"10","key":"2313_CR81","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1021\/acschemneuro.5c00050","volume":"16","author":"A Roy","year":"2025","unstructured":"Roy A et al (2025) The vicious consequences of chronic kidney disease on cognitive impairment and Alzheimer\u2019s disease. ACS Chem Neurosci 16(10):1847\u20131859","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"2313_CR82","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1146\/annurev.med.51.1.315","volume":"51","author":"P Ruggenenti","year":"2000","unstructured":"Ruggenenti P, Remuzzi G (2000) The role of protein traffic in the progression of renal diseases. Annu Rev Med 51(1):315\u2013327. https:\/\/doi.org\/10.1146\/annurev.med.51.1.315","journal-title":"Annu Rev Med"},{"issue":"4","key":"2313_CR83","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s00044-024-03203-5","volume":"33","author":"N Saini","year":"2024","unstructured":"Saini N et al (2024) Motor and non-motor symptoms, drugs, and their mode of action in Parkinson\u2019s disease (PD): a review. Med Chem Res 33(4):580\u2013599. https:\/\/doi.org\/10.1007\/s00044-024-03203-5","journal-title":"Med Chem Res"},{"key":"2313_CR84","unstructured":"Scalcon V (2018) Critical role of the thioredoxin and the glutathione systems in mitochondrial pathophysiology. Dissertation, Scalcon, Valeria"},{"key":"2313_CR85","doi-asserted-by":"publisher","unstructured":"Sculier C, Gaspard N (2017) Electrolyte disturbances and critical care seizures in critical care: a guide to diagnosis and therapeutics. Springer 291\u2013310. https:\/\/doi.org\/10.1007\/978-3-319-49557-6_18","DOI":"10.1007\/978-3-319-49557-6_18"},{"issue":"1","key":"2313_CR86","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s11033-024-09520-7","volume":"51","author":"K Sharma","year":"2024","unstructured":"Sharma K et al (2024) Interplay between \u03b1-synuclein and parkin genes: insights of Parkinson\u2019s disease. Mol Biol Rep 51(1):586. https:\/\/doi.org\/10.1007\/s11033-024-09520-7","journal-title":"Mol Biol Rep"},{"issue":"4","key":"2313_CR87","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.3390\/ijms25042169","volume":"25","author":"AM Sheikh","year":"2024","unstructured":"Sheikh AM, Yano S, Tabassum S, Nagai A (2024) The role of the vascular system in degenerative diseases: mechanisms and implications. Int J Mol Sci 25(4):2169. https:\/\/doi.org\/10.3390\/ijms25042169","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2313_CR88","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s11011-025-01739-y","volume":"40","author":"MM Shokr","year":"2025","unstructured":"Shokr MM (2025) Rewiring brain immunity: targeting microglial metabolism for neuroprotection in neurodegenerative disorders. Metab Brain Dis 40(8):326. https:\/\/doi.org\/10.1007\/s11011-025-01739-y","journal-title":"Metab Brain Dis"},{"issue":"3\u20134","key":"2313_CR90","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1515\/bmc-2017-0005","volume":"8","author":"RK Singh","year":"2017","unstructured":"Singh RK et al (2017) Protein kinase C-\u03b1 and the regulation of diverse cell responses. Biomol concepts 8(3\u20134):143\u2013153","journal-title":"Biomol concepts"},{"issue":"6","key":"2313_CR89","doi-asserted-by":"publisher","first-page":"554","DOI":"10.3390\/brainsci14060554","volume":"14","author":"N Singh","year":"2024","unstructured":"Singh N et al (2024) Protein kinase C (PKC) in neurological health: implications for Alzheimer\u2019s disease and chronic alcohol consumption. Brain Sci 14(6):554. https:\/\/doi.org\/10.3390\/brainsci14060554","journal-title":"Brain Sci"},{"issue":"3","key":"2313_CR91","first-page":"1641","volume":"25","author":"TT Song","year":"2021","unstructured":"Song TT et al (2021) The important role of TFEB in autophagy-lysosomal pathway and autophagy-related diseases: a systematic review. Eur Rev Med Pharmacol Sci 25(3):1641\u20131649","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"2313_CR92","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1152\/physrev.00034.2007","volume":"88","author":"SF Steinberg","year":"2008","unstructured":"Steinberg SF (2008) Structural basis of protein kinase C isoform function. Physiol Rev 88(4):1341\u20131378. https:\/\/doi.org\/10.1152\/physrev.00034.2007","journal-title":"Physiol Rev"},{"key":"2313_CR93","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3389\/fphar.2015.00128","volume":"6","author":"SF Steinberg","year":"2015","unstructured":"Steinberg SF (2015) Mechanisms for redox-regulation of protein kinase C. Front Pharmacol 6:128. https:\/\/doi.org\/10.3389\/fphar.2015.00128","journal-title":"Front Pharmacol"},{"key":"2313_CR94","doi-asserted-by":"publisher","first-page":"903455","DOI":"10.3389\/fnagi.2022.903455","volume":"14","author":"Y Sun","year":"2022","unstructured":"Sun Y, Koyama Y, Shimada S (2022) Inflammation from peripheral organs to the brain: how does systemic inflammation cause neuroinflammation? Front Aging Neurosci 14:903455. https:\/\/doi.org\/10.3389\/fnagi.2022.903455","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"2313_CR95","doi-asserted-by":"publisher","first-page":"F1399","DOI":"10.1152\/ajprenal.00051.200","volume":"297","author":"V Thamilselvan","year":"2009","unstructured":"Thamilselvan V, Menon M, Thamilselvan S (2009) Oxalate-induced activation of PKC-\u03b1 and-\u03b4 regulates NADPH oxidase-mediated oxidative injury in renal tubular epithelial cells. Am J Physiology-Renal Physiol 297(5):F1399\u2013F1410. https:\/\/doi.org\/10.1152\/ajprenal.00051.200","journal-title":"Am J Physiology-Renal Physiol"},{"key":"2313_CR96","doi-asserted-by":"publisher","first-page":"627837","DOI":"10.3389\/fphys.2021.627837","volume":"12","author":"H Tirichen","year":"2021","unstructured":"Tirichen H et al (2021) Mitochondrial reactive oxygen species and their contribution in chronic kidney disease progression through oxidative stress. Front Physiol 12:627837. https:\/\/doi.org\/10.3389\/fphys.2021.627837","journal-title":"Front Physiol"},{"issue":"8","key":"2313_CR97","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.1007\/s10787-025-01869-w","volume":"33","author":"K Vashisht","year":"2025","unstructured":"Vashisht K et al (2025) Asperuloside as a promising multi-target agent for Alzheimer\u2019s disease: molecular mechanisms and therapeutic perspectives. Inflammopharmacology 33(8):4311\u20134321. https:\/\/doi.org\/10.1007\/s10787-025-01869-w","journal-title":"Inflammopharmacology"},{"issue":"22","key":"2313_CR98","doi-asserted-by":"publisher","first-page":"11207","DOI":"10.3390\/ijms262211207","volume":"26","author":"G Velikic","year":"2025","unstructured":"Velikic G et al (2025) Neurodegeneration as ecosystem failure: a new paradigm for prevention and treatment. Int J Mol Sci 26(22):11207. https:\/\/doi.org\/10.3390\/ijms262211207","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2313_CR99","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.3390\/cells11111732","volume":"11","author":"M Vidovi\u0107","year":"2022","unstructured":"Vidovi\u0107 M, Rikalovic MG (2022) Alpha-synuclein aggregation pathway in Parkinson\u2019s disease: current status and novel therapeutic approaches. Cells 11(11):1732. https:\/\/doi.org\/10.3390\/cells11111732","journal-title":"Cells"},{"issue":"2","key":"2313_CR100","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s11033-021-06896-8","volume":"49","author":"S Vishwakarma","year":"2022","unstructured":"Vishwakarma S, Singh S, Singh TG (2022) Pharmacological modulation of cytokines correlating with neuroinflammatory cascades in epileptogenesis. Mol Biol Rep 49(2):1437\u20131452. https:\/\/doi.org\/10.1007\/s11033-021-06896-8","journal-title":"Mol Biol Rep"},{"issue":"4","key":"2313_CR102","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1159\/000524475","volume":"8","author":"Z Xie","year":"2022","unstructured":"Xie Z et al (2022) Chronic kidney disease and cognitive impairment: the kidney-brain axis. Kidney Dis 8(4):275\u2013285. https:\/\/doi.org\/10.1159\/000524475","journal-title":"Kidney Dis"},{"issue":"6","key":"2313_CR101","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3390\/antiox13060659","volume":"13","author":"T Xie","year":"2024","unstructured":"Xie T, Yao L, Li X (2024) Advance in iron metabolism, oxidative stress, and cellular dysfunction in experimental and human kidney diseases. Antioxidants 13(6):659. https:\/\/doi.org\/10.3390\/antiox13060659","journal-title":"Antioxidants"},{"issue":"3","key":"2313_CR103","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2332\/allergolint.55.245","volume":"55","author":"T Yamaguchi","year":"2006","unstructured":"Yamaguchi T, Suzuki M, Kimura H, Kato M (2006) Role of protein kinase C in eosinophil function. Allergology Int 55(3):245\u2013252. https:\/\/doi.org\/10.2332\/allergolint.55.245","journal-title":"Allergology Int"},{"issue":"7","key":"2313_CR104","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41581-018-0018-2","volume":"14","author":"T Yang","year":"2018","unstructured":"Yang T et al (2018) The gut microbiota and the brain\u2013gut\u2013kidney axis in hypertension and chronic kidney disease. Nat Rev Nephrol 14(7):442\u2013456. https:\/\/doi.org\/10.1038\/s41581-018-0018-2","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"2313_CR105","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41531-025-00926-z","volume":"11","author":"X Yang","year":"2025","unstructured":"Yang X et al (2025) Disruption of axonal transport in Parkinson\u2019s disease: the role of pathological \u03b1-Syn and AMPK\/p38 MAPK signaling. npj Parkinson\u2019s Disease 11(1):114. https:\/\/doi.org\/10.1038\/s41531-025-00926-z","journal-title":"npj Parkinson\u2019s Disease"},{"issue":"3","key":"2313_CR106","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41593-024-01866-2","volume":"28","author":"X Yuan","year":"2025","unstructured":"Yuan X et al (2025) Propagation of pathologic \u03b1-synuclein from the kidney to the brain may contribute to Parkinson\u2019s disease. Nat Neurosci 28(3):577\u2013588. https:\/\/doi.org\/10.1038\/s41593-024-01866-2","journal-title":"Nat Neurosci"},{"key":"2313_CR107","doi-asserted-by":"publisher","first-page":"872134","DOI":"10.3389\/fnagi.2022.872134","volume":"14","author":"X Zang","year":"2022","unstructured":"Zang X, Chen S, Zhu J, Ma J, Zhai Y (2022) The emerging role of central and peripheral immune systems in neurodegenerative diseases. Front Aging Neurosci 14:872134. https:\/\/doi.org\/10.3389\/fnagi.2022.872134","journal-title":"Front Aging Neurosci"},{"key":"2313_CR108","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3389\/fnagi.2018.00370","volume":"10","author":"G Zhang","year":"2018","unstructured":"Zhang G et al (2018) New perspectives on roles of alpha-synuclein in Parkinson\u2019s disease. Front Aging Neurosci 10:370. https:\/\/doi.org\/10.3389\/fnagi.2018.00370","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"2313_CR109","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1177\/1073858420943180","volume":"27","author":"H Zheng","year":"2021","unstructured":"Zheng H et al (2021) \u03b1-synuclein in Parkinson\u2019s disease: does a prion-like mechanism of propagation from periphery to the brain play a role? Neuroscientist 27(4):367\u2013387","journal-title":"neuroscientist"},{"issue":"4","key":"2313_CR110","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.3233\/JAD-220742","volume":"90","author":"C Zhu","year":"2022","unstructured":"Zhu C et al (2022) A conceptual study on the peripheral clearance of brain-derived \u03b1-synuclein in humans. J Alzheimer\u2019s Disease 90(4):1485\u20131492. https:\/\/doi.org\/10.3233\/JAD-220742","journal-title":"J Alzheimer\u2019s Disease"},{"key":"2313_CR111","doi-asserted-by":"publisher","first-page":"1535356","DOI":"10.3389\/fmicb.2025.1535356","volume":"16","author":"J Zhu","year":"2025","unstructured":"Zhu J et al (2025) The influence of gut microbiota on the gut-brain-kidney axis and its implications for chronic kidney disease. Front Microbiol 16:1535356. https:\/\/doi.org\/10.3389\/fmicb.2025.1535356","journal-title":"Front Microbiol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02313-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02313-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02313-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:43:25Z","timestamp":1787924605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02313-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":115,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2313"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02313-3","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"17 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}